Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, Sorafenib in advanced clear-cell renal-cell carcinoma, in N. Engl. J. Med., vol. 356, n. 2, gennaio 2007, pp. 125–34, DOI:10.1056/NEJMoa060655, PMID17215530.
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, Sorafenib in advanced clear-cell renal-cell carcinoma, in N. Engl. J. Med., vol. 356, n. 2, gennaio 2007, pp. 125–34, DOI:10.1056/NEJMoa060655, PMID17215530.
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, Sorafenib in advanced clear-cell renal-cell carcinoma, in N. Engl. J. Med., vol. 356, n. 2, gennaio 2007, pp. 125–34, DOI:10.1056/NEJMoa060655, PMID17215530.